Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/his.12484 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation.
Intern Med
August 2018
Department of Respiratory Medicine, Kumamoto University Hospital, Japan.
Pseudomesotheliomatous carcinoma of the lung is very rare, and reversible restrictive lung disease with pseudomesotheliomatous carcinoma has not yet been previously reported. We herein report a patient with HER2-positive non-small-cell lung cancer (NSCLC) showing pseudomesotheliomatous carcinoma who was successfully treated with bevacizumab combination chemotherapy. A 56-year-old Japanese woman with advanced NSCLC presented with dyspnea.
View Article and Find Full Text PDFPseudomesotheliomatous small-cell neuroendocrine carcinoma of the lung with calretinin expression.
Histopathology
May 2015
Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK.
Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
Respirology
November 2005
Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School, Kurashiki, Japan.
Objective: The aim of this study was to evaluate the clinicopathological features of lung cancer resembling malignant pleural mesothelioma.
Methodology: The seven patients studied had tumours showing an extensive pleural growth pattern, and were chosen from 1516 lung cancer patients diagnosed at two affiliated hospitals over a 17-year period.
Results: Histologically, five of these lung cancers were adenocarcinomas, one was a small cell carcinoma, and one a large cell carcinoma.
The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
Lung Cancer
May 2004
Department of Pathology, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan, ROC.
Thyroid transcription factor-1 (TTF-1) is a tissue-specific transcription factor expressed in the thyroid and lung. The clinical utility and limitation of TTF-1 in primary or metastatic carcinomas of the lung have not been previously studied in detail. We examined TTF-1 expression in 510 primary lung and 107 metastatic neoplasms.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!